DeepCyte Launches World's First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance

Source: PRNewswire· August 19, 2026

Proprietary training dataset spanning 300,000 cells and ~100 compounds positions DeepCyte to transform preclinical toxicology with mechanism-based prediction WILMINGTON, Del. and COPENHAGEN, Denmark, Aug. 19, 2026 /PRNewswire/ -- DeepCyte Inc., a techbio comp…

This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire

More in Enterprise & Adoption

View all